RWA Wealth Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.94M | Buy |
57,423
+536
| +0.9% | +$47.8K | 0.06% | 158 |
|
|
2026
Q1 | $4.09M | Buy |
56,887
+96
| +0.2% | +$7.39K | 0.04% | 188 |
|
|
2025
Q4 | $4.51M | Buy |
56,791
+3,042
| +6% | +$240K | 0.05% | 175 |
|
|
2025
Q3 | $4.05M | Sell |
53,749
-152
| -0.3% | -$10.4K | 0.05% | 194 |
|
|
2025
Q2 | $3.72M | Sell |
53,901
-1,203
| -2% | -$78.9K | 0.05% | 187 |
|
|
2025
Q1 | $3.73M | Buy |
55,104
+2,744
| +5% | +$164K | 0.05% | 177 |
|
|
2024
Q4 | $2.35M | Sell |
52,360
-4,251
| -8% | -$238K | 0.03% | 230 |
|
|
2024
Q3 | $3.56M | Buy |
56,611
+465
| +0.8% | +$27.1K | 0.04% | 191 |
|
|
2024
Q2 | $3.32M | Sell |
56,146
-4,303
| -7% | -$269K | 0.04% | 186 |
|
|
2024
Q1 | $4.82M | Sell |
60,449
-3,503
| -5% | -$268K | 0.06% | 153 |
|
|
2023
Q4 | $5.05M | Buy |
63,952
+12,217
| +24% | +$870K | 0.07% | 135 |
|
|
2023
Q3 | $3.61M | Sell |
51,735
-3,387
| -6% | -$240K | 0.08% | 97 |
|
|
2023
Q2 | $3.81M | Buy |
55,122
+51,691
| +1,507% | +$3.68M | 0.08% | 92 |
|
|
2023
Q1 | $255K | Hold |
3,431
| – | – | 0.01% | 229 |
|
|
2022
Q4 | $308K | Buy |
3,431
+149
| +5% | +$14.4K | 0.01% | 214 |
|
|
2022
Q3 | $313K | Buy |
3,282
+1
| +0% | +$99 | 0.02% | 195 |
|
|
2022
Q2 | $304K | Buy |
3,281
+491
| +18% | +$47.9K | 0.02% | 189 |
|
|
2022
Q1 | $282K | Buy |
2,790
+416
| +18% | +$43.7K | 0.02% | 215 |
|
|
2021
Q4 | $245K | Buy |
+2,374
| New | +$219K | 0.02% | 231 |
|
|
2020
Q1 | – | Sell |
-2,854
| Closed | -$212K | – | 207 |
|
|
2019
Q4 | $212K | Buy |
+2,854
| New | +$200K | 0.02% | 231 |
|
|
2019
Q1 | – | Sell |
-3,163
| Closed | -$207K | – | 231 |
|
|
2018
Q4 | $207K | Buy |
3,163
+162
| +5% | +$12.1K | 0.03% | 210 |
|
|
2018
Q3 | $236K | Buy |
3,001
+8
| +0.3% | +$572 | 0.03% | 207 |
|
|
2018
Q2 | $193K | Buy |
2,993
+905
| +43% | +$59.6K | 0.02% | 231 |
|
|
2018
Q1 | $130K | Sell |
2,088
-5,913
| -74% | -$424K | 0.02% | 236 |
|
|
2017
Q4 | $580K | Sell |
8,001
-43,150
| -84% | -$3.14M | 0.07% | 157 |
|
|
2017
Q3 | $4.16M | Buy |
51,151
+2,108
| +4% | +$167K | 0.47% | 61 |
|
|
2017
Q2 | $3.95M | Buy |
49,043
+845
| +2% | +$66.7K | 0.48% | 55 |
|
|
2017
Q1 | $3.78M | Buy |
48,198
+45,606
| +1,759% | +$3.64M | 0.5% | 56 |
|
|
2016
Q4 | $205K | Buy |
+2,592
| New | +$210K | 0.19% | 48 |
|
Other funds holding CVS
RWA Wealth Partners's CVS Position: Q2 2026 in Review
RWA Wealth Partners increased its CVS Health (CVS) stake by 0.94% in Q2 2026, buying an estimated $47.8K and bringing the position to 57,423 shares worth $5.94M. The position accounts for 0.06% of the portfolio, ranked #158.
RWA Wealth Partners first reported a position in CVS in Q4 2016 and has held it in 29 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- RWA Wealth Partners held 57,423 shares of CVS Health worth $5.94M as of Q2 2026.
- RWA Wealth Partners bought 536 CVS Health shares in Q2 2026, an estimated $47.8K.
- CVS Health made up 0.06% of RWA Wealth Partners's portfolio in Q2 2026, its #158 holding.
- RWA Wealth Partners first reported a position in CVS Health in Q4 2016 and has held it in 29 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.